FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2035936679> ?p ?o ?g. }

• W2035936679 endingPage "874" @default.
• W2035936679 startingPage "866" @default.
• W2035936679 abstract "Background: Hemodialysis patients have uremic dyslipidemia, represented by elevated serum intermediate-density lipoprotein cholesterol (IDL-C) levels, and an increased cardiovascular mortality rate. This study was performed to determine the low-dose effects of the angiotensin II receptor blocker losartan and the angiotensin-converting enzyme inhibitor trandolapril on pulse wave velocity (PWV), which predicts cardiovascular morbidity and mortality in hemodialysis patients. Methods: Serum lipid levels and PWV were monitored for 12 months in 64 hemodialysis patients who were administered low doses of losartan or trandolapril or a placebo. Results: At the start of the study, there were no differences in patient characteristics among the 3 groups. PWV tended to increase in the placebo group during the 12-month study period, but decreased significantly in the losartan and trandolapril groups, and decreases in PWV were similar in the losartan and trandolapril groups. There were no changes in blood pressure, hematocrit, erythropoietin dose, ankle-brachial index, serum lipid levels, serum 8-isoprostane levels, or serum C-reactive protein levels during the 12-month study period, but there was an increase in serum triglyceride levels in the losartan group and a decrease in serum IDL-C levels in the losartan and trandolapril groups. Conclusion: In hemodialysis patients, trandolapril is as effective as losartan in decreasing PWV independent of its depressor effect and in suppressing elevated IDL-C levels. Long-term blockade of the renin-angiotensin system may have a beneficial effect on the acceleration of atherosclerosis and uremic dyslipidemia. Background: Hemodialysis patients have uremic dyslipidemia, represented by elevated serum intermediate-density lipoprotein cholesterol (IDL-C) levels, and an increased cardiovascular mortality rate. This study was performed to determine the low-dose effects of the angiotensin II receptor blocker losartan and the angiotensin-converting enzyme inhibitor trandolapril on pulse wave velocity (PWV), which predicts cardiovascular morbidity and mortality in hemodialysis patients. Methods: Serum lipid levels and PWV were monitored for 12 months in 64 hemodialysis patients who were administered low doses of losartan or trandolapril or a placebo. Results: At the start of the study, there were no differences in patient characteristics among the 3 groups. PWV tended to increase in the placebo group during the 12-month study period, but decreased significantly in the losartan and trandolapril groups, and decreases in PWV were similar in the losartan and trandolapril groups. There were no changes in blood pressure, hematocrit, erythropoietin dose, ankle-brachial index, serum lipid levels, serum 8-isoprostane levels, or serum C-reactive protein levels during the 12-month study period, but there was an increase in serum triglyceride levels in the losartan group and a decrease in serum IDL-C levels in the losartan and trandolapril groups. Conclusion: In hemodialysis patients, trandolapril is as effective as losartan in decreasing PWV independent of its depressor effect and in suppressing elevated IDL-C levels. Long-term blockade of the renin-angiotensin system may have a beneficial effect on the acceleration of atherosclerosis and uremic dyslipidemia." @default.
• W2035936679 created "2016-06-24" @default.
• W2035936679 creator A5001299618 @default.
• W2035936679 creator A5003412793 @default.
• W2035936679 creator A5003939533 @default.
• W2035936679 creator A5009044898 @default.
• W2035936679 creator A5020080600 @default.
• W2035936679 creator A5025921038 @default.
• W2035936679 creator A5033356018 @default.
• W2035936679 creator A5033714545 @default.
• W2035936679 creator A5048419184 @default.
• W2035936679 creator A5088931960 @default.
• W2035936679 date "2005-05-01" @default.
• W2035936679 modified "2023-09-25" @default.
• W2035936679 title "Low Doses of Losartan and Trandolapril Improve Arterial Stiffness in Hemodialysis Patients" @default.
• W2035936679 cites W1512559452 @default.
• W2035936679 cites W1966368391 @default.
• W2035936679 cites W1975887243 @default.
• W2035936679 cites W1978115696 @default.
• W2035936679 cites W1995544566 @default.
• W2035936679 cites W2021370719 @default.
• W2035936679 cites W2021727310 @default.
• W2035936679 cites W2026546429 @default.
• W2035936679 cites W2026772606 @default.
• W2035936679 cites W2028260112 @default.
• W2035936679 cites W2041274276 @default.
• W2035936679 cites W2048748448 @default.
• W2035936679 cites W2051603643 @default.
• W2035936679 cites W2067089759 @default.
• W2035936679 cites W2078142203 @default.
• W2035936679 cites W2082201000 @default.
• W2035936679 cites W2088859305 @default.
• W2035936679 cites W2091826616 @default.
• W2035936679 cites W2107529916 @default.
• W2035936679 cites W2120733514 @default.
• W2035936679 cites W2126021826 @default.
• W2035936679 cites W2129697991 @default.
• W2035936679 cites W2131599914 @default.
• W2035936679 cites W2132327472 @default.
• W2035936679 cites W2141250561 @default.
• W2035936679 cites W2141714231 @default.
• W2035936679 cites W2141870462 @default.
• W2035936679 cites W2150147307 @default.
• W2035936679 cites W2155321540 @default.
• W2035936679 cites W2173345687 @default.
• W2035936679 cites W2324915698 @default.
• W2035936679 cites W2337703243 @default.
• W2035936679 doi "https://doi.org/10.1053/j.ajkd.2005.02.022" @default.
• W2035936679 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15861352" @default.
• W2035936679 hasPublicationYear "2005" @default.
• W2035936679 type Work @default.
• W2035936679 sameAs 2035936679 @default.
• W2035936679 citedByCount "79" @default.
• W2035936679 countsByYear W20359366792012 @default.
• W2035936679 countsByYear W20359366792013 @default.
• W2035936679 countsByYear W20359366792014 @default.
• W2035936679 countsByYear W20359366792015 @default.
• W2035936679 countsByYear W20359366792016 @default.
• W2035936679 countsByYear W20359366792017 @default.
• W2035936679 countsByYear W20359366792018 @default.
• W2035936679 countsByYear W20359366792019 @default.
• W2035936679 countsByYear W20359366792020 @default.
• W2035936679 countsByYear W20359366792021 @default.
• W2035936679 countsByYear W20359366792022 @default.
• W2035936679 countsByYear W20359366792023 @default.
• W2035936679 crossrefType "journal-article" @default.
• W2035936679 hasAuthorship W2035936679A5001299618 @default.
• W2035936679 hasAuthorship W2035936679A5003412793 @default.
• W2035936679 hasAuthorship W2035936679A5003939533 @default.
• W2035936679 hasAuthorship W2035936679A5009044898 @default.
• W2035936679 hasAuthorship W2035936679A5020080600 @default.
• W2035936679 hasAuthorship W2035936679A5025921038 @default.
• W2035936679 hasAuthorship W2035936679A5033356018 @default.
• W2035936679 hasAuthorship W2035936679A5033714545 @default.
• W2035936679 hasAuthorship W2035936679A5048419184 @default.
• W2035936679 hasAuthorship W2035936679A5088931960 @default.
• W2035936679 hasConcept C126322002 @default.
• W2035936679 hasConcept C134018914 @default.
• W2035936679 hasConcept C27016395 @default.
• W2035936679 hasConcept C2775850156 @default.
• W2035936679 hasConcept C2778063415 @default.
• W2035936679 hasConcept C2778096610 @default.
• W2035936679 hasConcept C2778319312 @default.
• W2035936679 hasConcept C2778728240 @default.
• W2035936679 hasConcept C2779611605 @default.
• W2035936679 hasConcept C2780288358 @default.
• W2035936679 hasConcept C2908929049 @default.
• W2035936679 hasConcept C511355011 @default.
• W2035936679 hasConcept C71924100 @default.
• W2035936679 hasConcept C84393581 @default.
• W2035936679 hasConceptScore W2035936679C126322002 @default.
• W2035936679 hasConceptScore W2035936679C134018914 @default.
• W2035936679 hasConceptScore W2035936679C27016395 @default.
• W2035936679 hasConceptScore W2035936679C2775850156 @default.
• W2035936679 hasConceptScore W2035936679C2778063415 @default.
• W2035936679 hasConceptScore W2035936679C2778096610 @default.
• W2035936679 hasConceptScore W2035936679C2778319312 @default.
• W2035936679 hasConceptScore W2035936679C2778728240 @default.

• next